|
HSP90AB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.759400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.593000E-01 |
| Normal-vs-Stage2 |
6.408000E-01 |
| Normal-vs-Stage3 |
2.078600E-01 |
| Normal-vs-Stage4 |
6.425600E-01 |
| Stage1-vs-Stage2 |
8.320600E-01 |
| Stage1-vs-Stage3 |
2.133400E-01 |
| Stage1-vs-Stage4 |
3.072600E-01 |
| Stage2-vs-Stage3 |
5.383400E-01 |
| Stage2-vs-Stage4 |
3.533600E-01 |
| Stage3-vs-Stage4 |
6.148100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.208400E-01 |
| Normal-vs-AfricanAmerican |
5.645000E-01 |
| Normal-vs-Asian |
5.390800E-01 |
| Caucasian-vs-AfricanAmerican |
2.978400E-01 |
| Caucasian-vs-Asian |
2.156400E-01 |
| AfricanAmerican-vs-Asian |
9.056400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.821600E-01 |
| Normal-vs-Female |
6.975600E-01 |
| Male-vs-Female |
4.020800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.599400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.541000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.494030E-01 |
| Normal-vs-Age(81-100Yrs) |
8.320200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.473200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.779700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.461800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.110970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.971000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.432000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.359700E-02 |
| Classical-VS-Follicular |
2.17900000265558E-08 |
| Classical-VS-Other |
6.386800E-01 |
| Classical-VS-Normal |
4.867600E-01 |
| Tall-VS-Follicular |
9.650100E-02 |
| Tall-VS-Other |
9.101800E-01 |
| Tall-VS-Normal |
2.129000E-01 |
| Follicular-VS-Other |
5.515000E-01 |
| Follicular-VS-Normal |
3.457900E-03 |
| Other-VS-Normal |
6.767800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.007000E-01 |
| Normal-vs-N1 |
7.772500E-02 |
| N0-vs-N1 |
2.046800E-01 |
|
|
